Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
The 3 best performing ASX shares in the week of 7 November 2022
Marc Kennis, November 14, 2022
The 3 best performing ASX shares in the week of 7 November 2022
The 3 best performing ASX shares of the week starting 7 November 2022 were Invictus Energy (ASX:IVZ), up 108.7%, Aeris Resources (ASX:AIS), up 57.8%, and Novatti Group (ASX:NOV), up 43.2%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Invictus Energy (ASX:IVZ)
Industry: Energy
Invictus Energy (ASX:IVZ) is an independent upstream oil and gas company. The company is opening rift basins in onshore Africa – the Cabora Bassa Basin – in northern Zimbabwe through a high impact exploration program.
Market Cap: $210m
12 month high / low: $0.10 – $0.36
2. Aeris Resources (ASX:AIS)
Industry: Resources
Aeris Resources (ASX:AIS) is a diversified mining and exploration company listed on the Australian Securities Exchange and headquartered in Brisbane, Queensland. During the year the company is involved in production and sale of copper, gold and silver and the exploration for copper and gold.
Market Cap: $349m
12 month high / low: $0.275 – $1.20
3. Novatti Group (ASX:NOV)
Industry: Industrials
Novatti Group (ASX:NOV) rounds out our 3 best performing ASX shares this week. NOV is a payment processing platform that facilitates mobile and alternative financial payments solutions and services.
Market Cap: $92m
12 month high / low: $0.15 – $0.43
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Recent Posts
Should you buy Nvidia shares in Australia?
Many investors are likely wondering if they should buy Nvidia shares in Australia? Others still might be wondering just who…
Mesoblast (ASX:MSB): Will it thrive or just survive in 2024?
Mesoblast’s (ASX:MSB) struggle with regenerative medicine in 2023 involved kеy financial movеs as wеll as opеrational rеstructurings. Thе entity which…
Star Entertainment Group … the house doesn’t always win
Thе recently released 2023 annual rеport of Star Entertainment Group portrays an intricatе fiscal position featuring extensive debt rеduction, but…